X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (5) 5
humans (5) 5
male (5) 5
index medicus (4) 4
adult (3) 3
chelation (3) 3
complications (3) 3
deferiprone (3) 3
hematology (3) 3
iron overload (3) 3
management (3) 3
adolescent (2) 2
beta-thalassemia (2) 2
bleomycin (2) 2
cancer (2) 2
chelation therapy - methods (2) 2
chemotherapy (2) 2
deferoxamine (2) 2
experience (2) 2
italy - epidemiology (2) 2
mortality (2) 2
oncology (2) 2
pancreatic cancer (2) 2
prognosis (2) 2
risk factors (2) 2
safety (2) 2
survival (2) 2
therapy (2) 2
transfusion (2) 2
urology & nephrology (2) 2
-epigallocatechin-3-gallate (1) 1
1,2-dimethyl-3-hydroxypyrid-4-one (1) 1
ablation (1) 1
adverse reactions (1) 1
aesthetics (1) 1
aged (1) 1
albumin excretion (1) 1
ambulatory care facilities - statistics & numerical data (1) 1
antidiabetic drugs (1) 1
antitumor effectiveness (1) 1
apoptosis (1) 1
beta-thalassemia - complications (1) 1
beta-thalassemia - drug therapy (1) 1
beta-thalassemia - etiology (1) 1
beta-thalassemia - mortality (1) 1
beta-thalassemia - therapy (1) 1
beta-thalassemia major (1) 1
bildung, biography and autobiography (1) 1
biomarkers - analysis (1) 1
blood transfusion - methods (1) 1
blood transfusion - statistics & numerical data (1) 1
blood-pressure control (1) 1
body mass index (1) 1
cardiac disease (1) 1
cardiomyopathy (1) 1
cardiovascular disease (1) 1
cardiovascular events (1) 1
cardiovascular prevention (1) 1
case-control studies (1) 1
catechin (1) 1
cell proliferation (1) 1
chelation-therapy (1) 1
child (1) 1
child, preschool (1) 1
chronic uremia (1) 1
chronic-hemodialysis patients (1) 1
cisplatin (1) 1
clinical study (1) 1
clinical trials (1) 1
computer simulation (1) 1
congestive heart failure (1) 1
cooperation (1) 1
coronary-artery disease (1) 1
cost of the disease (1) 1
creatinine (1) 1
critical theory (1) 1
cuba (1) 1
curcumin (1) 1
deferiprone, dose rationale, paediatrics, pharmacokinetic bridging, thalassaemia (1) 1
deferoxamine - therapeutic use (1) 1
desferrioxamine (1) 1
diabetes (1) 1
diabetes mellitus (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diagnosis (1) 1
dialysis (1) 1
disease progression (1) 1
dna damage (1) 1
dose rationale (1) 1
dose-response relationship, drug (1) 1
drug administration schedule (1) 1
drug-delivery (1) 1
efficacy (1) 1
electrochemotherapy (1) 1
endocrinology & metabolism (1) 1
epidemiology (1) 1
epidermal growth factor receptors (1) 1
esthetic and sociological critical theory (1) 1
ethics (1) 1
exile (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Infectious agents and cancer, ISSN 1750-9378, 2015, Volume 10, Issue 1, p. 22
...[sup.1], Mauro Piccirillo[sup.1], Alfonso Amore[sup.1], Raimondo Di Giacomo[sup.1], Aurelio Nasto[sup.1], Vincenza Granata[sup.3], Antonella Petrillo[sup.3... 
Cell proliferation | Bleomycin | (-)-Epigallocatechin-3-gallate | Pancreatic cancer | Apoptosis | RECOGNITION | GREEN TEA POLYPHENOLS | CURCUMIN | PREVENTION | OXALIPLATIN | IMMUNOLOGY | PTEROSTILBENE | GEMCITABINE | THERAPY | CISPLATIN | ONCOLOGY | Catechin | Chemotherapy | Growth | DNA damage | Mortality | Green tea | Cancer
Journal Article
Haematologica, ISSN 0390-6078, 10/2006, Volume 91, Issue 10, pp. 1420 - 1421
This retrospective one to one matched case-control study was aimed at evaluating risk factors for death in beta-thalassemic patients followed in Italian... 
Desferrioxamine | Iron overload | Deferiprone | β-thalassemia | beta-Thalassemia - drug therapy | beta-Thalassemia - etiology | Humans | Risk Factors | Adolescent | Adult | Female | Male | Retrospective Studies | beta-Thalassemia - mortality | Case-Control Studies | deferiprone | SURVIVAL | iron overload | desferrioxamine | DEFEROXAMINE | HEMATOLOGY | beta-thalassemia
Journal Article
Kidney International, ISSN 0085-2538, 01/2000, Volume 57, Issue S74, pp. S94 - S99
Patient selection affects end-stage renal disease outcome comparisons. Geographic differences in dialysis patient outcome could be partially explained by... 
dialysis | cardiovascular disease | congestive heart failure | Cardiovascular disease | Dialysis | Congestive heart failure | SURVIVAL | DIAGNOSIS | CORONARY-ARTERY DISEASE | RISK-FACTORS | MYOCARDIAL-INFARCTION | CARDIOMYOPATHY | ISCHEMIC-HEART-DISEASE | FAILURE | UROLOGY & NEPHROLOGY | CHRONIC UREMIA
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4567 - 4567
Abstract Background: In 2004 seven Italian centers reported survival data for patients with thalassemia major (TM) and showed that heart disease due to iron... 
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 2000, Volume 15, Issue 5, pp. 69 - 80
Journal Article
Jornal Interdisciplinar de Biociências, ISSN 2448-0002, 01/2020, Volume 4, Issue 1, p. 35
A compactação de fezes endurecidas no interior do trato intestinal é denominada de fecaloma, a qual está atrelada a fatores que interfiram na excreção normal... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.